Tag Archives: LPT

Best Undervalued Stocks To Own For 2019

Comcast Chairman and CEO Brian Roberts may have been less disappointed about losing a bidding war with the Walt Disney Company for parts of Twenty-First Century Fox than he was about the aftermath.

“We found it was undervalued. We put in a price. Eventually, Disney offered more and we walked away,” Roberts, whose company owns NBCUniversal, which owns CNBC and CNBC.com, recounted to “Mad Money” host Jim Cramer in an interview.

But “one of [his] disappointments this year” was that “people then took that and made a narrative that said we didn’t love our core business when, in fact, our core business is having a renaissance,” Roberts said on Thursday.

Describing a Comcast that has “pivoted” from being a traditional cable and entertainment provider to a technology-focused monolith, Roberts — whose company is still in the throes of bidding on European cable giant Sky — said his focus has turned to innovation, content and connectivity.

Best Undervalued Stocks To Own For 2019: Energizer Holdings, Inc.(ENR)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    SenesTech, Inc. (NASDAQ: SNES) shares jumped 113.5 percent to $0.6737 after the California Department of Pesticide Regulation proposed to register the company's ContraPest for sale and use in California.
    AgEagle Aerial Systems, Inc. (NASDAQ: UAVS) shares rose 35.34 percent to close at $3.32.
    Art's-Way Manufacturing Co., Inc. (NASDAQ: ARTW) shares gained 30.36 percent to $3.65.
    Xtant Medical Holdings, Inc. (NYSE: XTNT) shares jumped 25.6 percent to $7.4701 after the company disclosed that it has received the FDA clearance for InTice™-C Porous Titanium Cervical Interbody System.
    VAALCO Energy, Inc. (NYSE: EGY) shares surged 20 percent to $2.495.
    TransGlobe Energy Corporation (NASDAQ: TGA) surged 17.04 percent to $2.61.
    Boxlight Corporation (NASDAQ: BOXL) gained 15 percent to $8.32 after the company announced an exclusive partnership with Multi Touch Interactives to strengthen the development of next generation interactive educational activities.
    Arcimoto, Inc. (NASDAQ: FUV) gained 15 percent to $3.39.
    MB Financial, Inc. (NASDAQ: MBFI) rose 13.7 percent to $49.64. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock.
    FRONTEO, Inc. (NASDAQ: FTEO) shares rose 11.8 percent to $20.956.
    TransEnterix, Inc. (NYSE: TRXC) shares jumped 11.1 percent to $3.38.
    21Vianet Group, Inc. (NASDAQ: VNET) rose 10.6 percent to $7.41.
    NII Holdings, Inc. (NASDAQ: NIHD) shares gained 9 percent to $2.32.
    Kelly Services, Inc. (NASDAQ: KELYA) rose 7.6 percent to $24.19. Northcoast Research upgraded Kelly Services from Neutral to Buy.
    LaSalle Hotel Properties (NYSE: LHO) shares climbed 5.6 percent to $33.70. Blackstone Group LP (NYSE: BX) will buy LaSalle Hotel Properties in a $4.8 billion deal, Bloomberg reported.
    Alteryx, Inc. (NYSE: AYX) gained 5.5 percent to $32.56. KeyBanc upgraded Alteryx from Sector Weight to Overweight.
    Energizer Holdings, Inc. (NYSE:
  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Energizer (ENR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Great West Life Assurance Co. Can increased its position in shares of Energizer Holdings Inc (NYSE:ENR) by 2.1% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 209,651 shares of the company’s stock after purchasing an additional 4,282 shares during the quarter. Great West Life Assurance Co. Can’s holdings in Energizer were worth $13,209,000 at the end of the most recent quarter.

  • [By Shane Hupp]

    Energizer Holdings Inc (NYSE:ENR) was the target of unusually large options trading on Tuesday. Investors bought 1,550 call options on the stock. This is an increase of approximately 1,225% compared to the typical daily volume of 117 call options.

  • [By Lisa Levin] Gainers
    SenesTech, Inc. (NASDAQ: SNES) shares surged 296.07 percent to close at $1.25 on Monday after the California Department of Pesticide Regulation proposed to register the company's ContraPest for sale and use in California.
    AgEagle Aerial Systems, Inc. (NASDAQ: UAVS) shares gained 19.59 percent to close at $2.93.
    TransGlobe Energy Corporation (NASDAQ: TGA) rose 18.39 percent to close at $2.64 on Monday.
    Sears Hometown and Outlet Stores, Inc. (NASDAQ: SHOS) shares gained 15.91 percent to close at $2.55.
    VAALCO Energy, Inc. (NYSE: EGY) shares jumped 14.9 percent to close at $2.39.
    Resonant Inc. (NASDAQ: RESN) climbed 13.96 percent to close at $4.49.
    Chesapeake Energy Corporation (NYSE: CHK) shares rose 13.55 percent to close at $4.61 on Monday.
    Lilis Energy, Inc. (NYSE: LLEX) surged 13.09 percent to close at $5.01.
    MB Financial, Inc. (NASDAQ: MBFI) gained 12.9 percent to close at $49.28. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock.
    TransEnterix, Inc. (NYSE: TRXC) shares rose 12.83 percent to close at $3.43.
    World Wrestling Entertainment, Inc. (NYSE: WWE) jumped 12.52 percent to close at $57.86 on Reports that it has reached a deal with Fox for Its 'Smackdown Live' program.
    Eastman Kodak Company (NASDAQ: KODK) rose 12.38 percent to close at $5.90.
    NuCana plc (NASDAQ: NCNA) climbed 11.94 percent to close at $26.44. NuCana appointed Dr. Cyrille Leperlier to its Board as an independent non-executive Director.
    Aqua Metals, Inc. (NASDAQ: AQMS) rose 11.83 percent to close at $3.97 on Monday.
    Huami Corporation (NYSE: HMI) shares jumped 11.27 percent to close at $10.17 following Q1 results.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 9.55 percent to close at $7.34.
    Boxlight Corporation (NASDAQ: BOXL) rose 8.56 percent to close at $7.86 after the company announced an exclusive partnership with Multi Touch Interactives to strengthen the de

Best Undervalued Stocks To Own For 2019: Cotiviti Holdings, Inc. (COTV)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Cotiviti (COTV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Cotiviti Holdings, Inc. (NYSE:COTV) – Equities research analysts at Jefferies Group lowered their FY2018 earnings estimates for Cotiviti in a report issued on Wednesday, May 2nd. Jefferies Group analyst S. Dodge now expects that the business services provider will post earnings per share of $1.68 for the year, down from their previous estimate of $1.71. Jefferies Group also issued estimates for Cotiviti’s FY2019 earnings at $1.87 EPS.

  • [By Steve Symington]

    Shares of Cotiviti Holdings Inc. (NYSE:COTV) were up 10.2% as of 1:00 p.m. EDT Tuesday after Veritas Capital agreed to acquire the healthcare payment solutions company.

Best Undervalued Stocks To Own For 2019: Magic Software Enterprises Ltd.(MGIC)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Magic Software Enterprises (NASDAQ:MGIC) was upgraded by BidaskClub from a “strong sell” rating to a “sell” rating in a report released on Thursday.

  • [By Logan Wallace]

    ValuEngine lowered shares of Magic Software Enterprises (NASDAQ:MGIC) from a buy rating to a hold rating in a report issued on Monday.

    Several other equities research analysts have also recently issued reports on MGIC. Zacks Investment Research raised shares of Magic Software Enterprises from a sell rating to a hold rating in a research report on Wednesday, January 17th. BidaskClub cut shares of Magic Software Enterprises from a sell rating to a strong sell rating in a research report on Tuesday, January 23rd. Finally, HC Wainwright set a $10.00 target price on shares of Magic Software Enterprises and gave the stock a buy rating in a research report on Thursday, March 1st. Two analysts have rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the company’s stock. The company has an average rating of Hold and an average target price of $9.81.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Magic Software Enterprises (MGIC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    HC Wainwright set a $10.00 target price on Magic Software Enterprises (NASDAQ:MGIC) in a research note released on Thursday morning. The firm currently has a buy rating on the software maker’s stock.

Best Undervalued Stocks To Own For 2019: Liberty Property Trust(LPT)

Advisors’ Opinion:

  • [By Max Byerly]

    DiamondRock Hospitality (NYSE:DRH) and Liberty Property Trust (NYSE:LPT) are both mid-cap finance companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, earnings, profitability, valuation and dividends.

  • [By Logan Wallace]

    Retirement Systems of Alabama lifted its position in Liberty Property Trust (NYSE:LPT) by 4.5% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 387,171 shares of the real estate investment trust’s stock after purchasing an additional 16,658 shares during the quarter. Retirement Systems of Alabama’s holdings in Liberty Property Trust were worth $17,163,000 at the end of the most recent quarter.

  • [By Stephan Byrd]

    These are some of the media headlines that may have impacted Accern’s scoring:

    Get Liberty Property Trust alerts:

    Liberty Property Trust (LPT) Receives “Buy” Rating from SunTrust Banks (americanbankingnews.com) FY2019 Earnings Estimate for Liberty Property Trust (LPT) Issued By KeyCorp (americanbankingnews.com) $163.17 Million in Sales Expected for Liberty Property Trust (LPT) This Quarter (americanbankingnews.com) Liberty Property Trust (LPT) Given Consensus Recommendation of “Hold” by Brokerages (americanbankingnews.com)

    Several research firms have recently issued reports on LPT. Sandler O’Neill set a $44.00 target price on shares of Liberty Property Trust and gave the stock a “hold” rating in a report on Wednesday, July 25th. ValuEngine lowered shares of Liberty Property Trust from a “buy” rating to a “hold” rating in a report on Thursday, May 17th. Morgan Stanley lowered their target price on shares of Liberty Property Trust from $44.00 to $43.00 and set an “equal weight” rating for the company in a report on Thursday, June 14th. Stifel Nicolaus raised their target price on shares of Liberty Property Trust from $44.00 to $46.00 and gave the stock a “buy” rating in a report on Wednesday, July 25th. Finally, Zacks Investment Research upgraded shares of Liberty Property Trust from a “sell” rating to a “hold” rating in a report on Wednesday, August 8th. Six research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $44.83.

  • [By Shane Hupp]

    These are some of the media headlines that may have impacted Accern’s analysis:

    Get Liberty Property Trust alerts:

    Liberty Property Trust Announces Third Quarter 2018 Dividend (feeds.benzinga.com) Zacks: Brokerages Expect Liberty Property Trust (LPT) Will Announce Quarterly Sales of $160.48 Million (americanbankingnews.com) Liberty Property's The Navy Yard Portfolio Now 99% Leased (finance.yahoo.com) Zacks: Analysts Expect Liberty Property Trust (LPT) Will Announce Earnings of $0.65 Per Share (americanbankingnews.com) High Demand Keeps Liberty's Richmond, Norfolk Assets Occupied (finance.yahoo.com)

    Shares of LPT opened at $43.00 on Wednesday. The firm has a market cap of $6.36 billion, a price-to-earnings ratio of 16.60, a PEG ratio of 2.73 and a beta of 0.61. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.76 and a quick ratio of 1.76. Liberty Property Trust has a twelve month low of $37.77 and a twelve month high of $45.40.

  • [By Shane Hupp]

    DekaBank Deutsche Girozentrale lowered its position in shares of Liberty Property Trust (NYSE:LPT) by 11.7% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 12,176 shares of the real estate investment trust’s stock after selling 1,608 shares during the period. DekaBank Deutsche Girozentrale’s holdings in Liberty Property Trust were worth $515,000 as of its most recent SEC filing.

Best Undervalued Stocks To Own For 2019: Vanguard Total Bond Market ETF (BND)

Advisors’ Opinion:

  • [By Reuben Gregg Brewer]

    Investing in retirement is vastly different from investing during your primary working years. You need to switch from a focus on growing your capital to a focus on protecting your capital and living off of it. That means generating income becomes an increasingly important part of the mix — but only if it doesn’t require material increases in risk. Vanguard Total Bond Market ETF (NYSEMKT:BND), Vanguard Utilities ETF (NYSEMKT:VPU), and SPDR S&P Dividend ETF (NYSEMKT:SDY) are three exchange-traded funds, or ETFs, that will help you invest the right way after you retire.

  • [By Shane Hupp]

    APCM Wealth Management for Individuals cut its position in shares of Vanguard Total Bond Market ETF (NYSEARCA:BND) by 2.9% during the first quarter, HoldingsChannel.com reports. The firm owned 350,510 shares of the company’s stock after selling 10,464 shares during the quarter. Vanguard Total Bond Market ETF makes up approximately 9.7% of APCM Wealth Management for Individuals’ portfolio, making the stock its 3rd biggest position. APCM Wealth Management for Individuals’ holdings in Vanguard Total Bond Market ETF were worth $28,016,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Max Byerly]

    Fagan Associates Inc. lessened its holdings in Vanguard Total Bond Market ETF (NYSEARCA:BND) by 3.9% during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 22,804 shares of the company’s stock after selling 925 shares during the period. Fagan Associates Inc.’s holdings in Vanguard Total Bond Market ETF were worth $1,806,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Blocknode (CURRENCY:BND) traded 4.9% lower against the U.S. dollar during the 24 hour period ending at 23:00 PM ET on February 6th. Over the last seven days, Blocknode has traded 21.4% lower against the U.S. dollar. Blocknode has a market cap of $77,467.00 and $5.00 worth of Blocknode was traded on exchanges in the last 24 hours. One Blocknode coin can currently be bought for about $0.0006 or 0.00000019 BTC on exchanges including Cryptopia and CoinExchange.

  • [By Selena Maranjian]

    You can also opt for exchange-traded funds, or ETFs, that focus on the same indexes — such as the SPDR S&P 500 ETF (NYSEMKT: SPY), Vanguard Total Stock Market ETF (NYSEMKT: VTI), and Vanguard Total World Stock ETF (NYSEMKT: VT). You can balance out your portfolio with bonds via index mutual funds and ETFs, too. The Vanguard Total Bond Market ETF (NYSEMKT: BND) is one such option.

  • [By Joseph Griffin]

    UMB Bank N A MO trimmed its position in shares of Vanguard Total Bond Market ETF (NYSEARCA:BND) by 24.5% in the 2nd quarter, HoldingsChannel reports. The fund owned 38,206 shares of the company’s stock after selling 12,373 shares during the quarter. UMB Bank N A MO’s holdings in Vanguard Total Bond Market ETF were worth $3,026,000 as of its most recent SEC filing.

Top Medical Stocks To Own For 2019

Cambridge Trust Co. raised its holdings in Agilent Technologies Inc (NYSE:A) by 37.8% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 23,991 shares of the medical research company’s stock after buying an additional 6,586 shares during the quarter. Cambridge Trust Co.’s holdings in Agilent Technologies were worth $1,484,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the company. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in Agilent Technologies by 6.5% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 332,857 shares of the medical research company’s stock valued at $20,584,000 after buying an additional 20,253 shares during the last quarter. Nomura Asset Management Co. Ltd. raised its stake in Agilent Technologies by 7.3% during the second quarter. Nomura Asset Management Co. Ltd. now owns 48,718 shares of the medical research company’s stock valued at $3,013,000 after buying an additional 3,317 shares during the last quarter. Engineers Gate Manager LP purchased a new position in Agilent Technologies during the second quarter valued at $642,000. Sei Investments Co. raised its stake in Agilent Technologies by 42.3% during the second quarter. Sei Investments Co. now owns 136,141 shares of the medical research company’s stock valued at $8,419,000 after buying an additional 40,462 shares during the last quarter. Finally, Meridian Management Co. purchased a new position in Agilent Technologies during the second quarter valued at $1,531,000.

Top Medical Stocks To Own For 2019: Embraer-Empresa Brasileira de Aeronautica(ERJ)

Advisors’ Opinion:

  • [By Paul Ausick]

    Finally, CEO Dennis Muilenburg said Thursday that the company is nearing an agreement with Brazil’s Embraer S.A. (NYSE: ERJ) that would give Boeing a controlling stake in Embraer’s commercial jet business and leave the firm’s military business under Brazilian government control.

  • [By Demitrios Kalogeropoulos, Rich Smith, Danny Vena, Travis Hoium, and Dan Caplinger]

    Below, Motley Fool contributors highlight a few of those tempting investments. Read on to find out why UnitedHealth Group (NYSE:UNH), Vail Resorts (NYSE:MTN), The Trade Desk (NASDAQ:TTD), Embraer (NYSE:ERJ), and Brookfield Renewable Partners (NYSE:BEP) look like good buys today.

  • [By Lou Whiteman]

    The Air Force on Aug. 3 posted notice of plans to acquire a fleet of light attack planes beginning in late 2019, with a formal request for proposal expected in December. The notice said that only the AT-6 and the A-29, a rival made by Embraer (NYSE:ERJ) and Sierra Nevada, will be considered.

Top Medical Stocks To Own For 2019: Scorpio Tankers Inc.(STNG)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Scorpio Tankers (STNG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Scorpio Tankers Inc. (NYSE:STNG) gapped down before the market opened on Thursday . The stock had previously closed at $1.75, but opened at $1.82. Scorpio Tankers shares last traded at $1.81, with a volume of 169888 shares traded.

  • [By Rich Smith]

    Stocks don’t always make sense — a fact investors should be happy about after Scorpio Tankers (NYSE:STNG) posted a quarterly loss and an earnings miss this morning and then rocketed 15% in early trading.

  • [By Max Byerly]

    Scorpio Tankers Inc. (NYSE:STNG) has been given a consensus rating of “Buy” by the eleven research firms that are covering the company, Marketbeat reports. Two analysts have rated the stock with a sell rating, one has given a hold rating and eight have assigned a buy rating to the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $4.20.

Top Medical Stocks To Own For 2019: Iridium Communications Inc(IRDM)

Advisors’ Opinion:

  • [By Stephan Byrd]

    MetLife Investment Advisors LLC boosted its stake in shares of Iridium Communications Inc (NASDAQ:IRDM) by 14.9% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 44,054 shares of the technology company’s stock after purchasing an additional 5,698 shares during the period. MetLife Investment Advisors LLC’s holdings in Iridium Communications were worth $709,000 at the end of the most recent quarter.

  • [By Joseph Griffin]

    Iridium Communications (NASDAQ: IRDM) and AAC TECHNOLOGIE/ADR (OTCMKTS:AACAY) are both computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, profitability, institutional ownership and valuation.

  • [By Max Byerly]

    Iridium Communications (NASDAQ: IRDM) and Inseego (NASDAQ:INSG) are both small-cap computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, risk and profitability.

  • [By Stephen Mack]

    Iridium Communications Inc. (Nasdaq: IRDM) provides communication where land-based services won’t do. This includes communications for construction and utilities applications, or among aviation fleets for commercial and government purposes. It includes maritime applications, from fishing and merchant shipping to research vessels. And it includes communications for the U.S. Department of Defense, ranging from emergency communications in the field to keeping soldiers in touch with people back home.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Iridium Communications (IRDM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Medical Stocks To Own For 2019: Liberty Property Trust(LPT)

Advisors’ Opinion:

  • [By Max Byerly]

    DiamondRock Hospitality (NYSE:DRH) and Liberty Property Trust (NYSE:LPT) are both mid-cap finance companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, earnings, profitability, valuation and dividends.

  • [By Shane Hupp]

    DekaBank Deutsche Girozentrale lowered its position in shares of Liberty Property Trust (NYSE:LPT) by 11.7% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 12,176 shares of the real estate investment trust’s stock after selling 1,608 shares during the period. DekaBank Deutsche Girozentrale’s holdings in Liberty Property Trust were worth $515,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Liberty Property Trust (LPT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Medical Stocks To Own For 2019: Apple Hospitality REIT, Inc.(APLE)

Advisors’ Opinion:

  • [By Max Byerly]

    Apple Hospitality REIT Inc (NYSE:APLE) insider Glade M. Knight bought 10,000 shares of Apple Hospitality REIT stock in a transaction dated Monday, August 20th. The stock was acquired at an average cost of $17.63 per share, for a total transaction of $176,300.00. Following the completion of the acquisition, the insider now directly owns 10,098,933 shares in the company, valued at $178,044,188.79. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

  • [By Lee Jackson]

    Apple Hospitality REIT Inc. (NYSE: APLE) owns one of the largest portfolios of upscale, select-service hotels in the United States. Investors are paid a generous 6.67% yield. The shares traded at $17.95 early Thursday, in a 52-week range of $16.72 to $21.90. The consensus price objective is $19.25.

  • [By Joseph Griffin]

    Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp grew its holdings in Apple Hospitality REIT Inc (NYSE:APLE) by 118.0% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 421,700 shares of the real estate investment trust’s stock after purchasing an additional 228,300 shares during the period. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp owned approximately 0.18% of Apple Hospitality REIT worth $7,409,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    Shares of Apple Hospitality REIT Inc (NYSE:APLE) have earned a consensus recommendation of “Hold” from the nine ratings firms that are currently covering the firm, MarketBeat reports. Six equities research analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $19.75.

  • [By Ethan Ryder]

    Apple Hospitality REIT Inc (NYSE:APLE) reached a new 52-week low during mid-day trading on Thursday . The stock traded as low as $16.67 and last traded at $16.70, with a volume of 40427 shares trading hands. The stock had previously closed at $16.88.

  • [By Shane Hupp]

    Riverhead Capital Management LLC grew its position in Apple Hospitality REIT (NYSE:APLE) by 607.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 134,100 shares of the real estate investment trust’s stock after acquiring an additional 115,150 shares during the quarter. Riverhead Capital Management LLC owned about 0.06% of Apple Hospitality REIT worth $2,356,000 at the end of the most recent reporting period.

Top Medical Stocks To Own For 2019: CryoPort, Inc.(CYRX)

Advisors’ Opinion:

  • [By Max Byerly]

    CryoPort Inc (NASDAQ:CYRX) Director Richard J. Berman sold 10,000 shares of the firm’s stock in a transaction on Thursday, September 6th. The stock was sold at an average price of $14.00, for a total transaction of $140,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

  • [By Ethan Ryder]

    CryoPort (NASDAQ:CYRX) posted its quarterly earnings results on Thursday. The consumer goods maker reported ($0.10) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.07) by ($0.03), Briefing.com reports. The company had revenue of $4.02 million during the quarter, compared to the consensus estimate of $3.84 million. CryoPort had a negative return on equity of 47.36% and a negative net margin of 66.09%. The company’s revenue for the quarter was up 48.3% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.10) earnings per share.

  • [By Ethan Ryder]

    CryoPort (NASDAQ: CYRX) and C. H. Robinson (NASDAQ:CHRW) are both transportation companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, risk and analyst recommendations.

  • [By Shane Hupp]

    CryoPort (NASDAQ:CYRX) had its price objective lifted by Cowen from $11.00 to $16.00 in a research report sent to investors on Monday morning, MarketBeat.com reports. Cowen currently has an outperform rating on the consumer goods maker’s stock.

Top 10 Medical Stocks To Buy For 2019

It turns out that most Americans know very little about the state of their own medical benefits, particularly when it comes to out-of-pocket healthcare costs.

A survey released by Sun Life yesterday revealed that a whopping 54% of working Americans don’t know what the out-of-pocket maximum is for their own healthcare plans.

This statistic truly highlights the financial risk associated with individuals trying to save for retirement and successfully grow their wealth: that such planning cannot accurately be achieved without knowing first what kind of financial effect a major medical event could one day have on them.

Don’t Miss:Eight Times the Government Was Warned About Obamacare Fraud – and Did Nothing

To make matters worse, a particular niche of those surveyed revealed themselves to be arguably in an even tougher financial spot…

Top 10 Medical Stocks To Buy For 2019: Intercept Pharmaceuticals, Inc.(ICPT)

Advisors’ Opinion:

  • [By Sean Williams, Chuck Saletta, and Brian Feroldi]

    With this in mind, we picked the brains of three Motley Fool investors to gauge what biotech stock they believe investors should consider buying right now. Topping the list were mid-caps Intercept Pharmaceuticals (NASDAQ:ICPT) and Xencor (NASDAQ:XNCR), as well as biotech blue-chip Celgene (NASDAQ:CELG).

  • [By Max Byerly]

    News headlines about Intercept Pharmaceuticals (NASDAQ:ICPT) have trended somewhat positive recently, Accern Sentiment Analysis reports. The research group scores the sentiment of press coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Intercept Pharmaceuticals earned a news impact score of 0.12 on Accern’s scale. Accern also gave news articles about the biopharmaceutical company an impact score of 46.6381898611919 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Intercept Pharmaceuticals (ICPT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    US Bancorp DE grew its stake in Intercept Pharmaceuticals (NASDAQ:ICPT) by 821.6% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,751 shares of the biopharmaceutical company’s stock after purchasing an additional 1,561 shares during the period. US Bancorp DE’s holdings in Intercept Pharmaceuticals were worth $108,000 at the end of the most recent quarter.

  • [By Sean Williams]

    As you can see, there’s a lot of excitement in the NASH space at the moment, and plenty of big drug stocks are itching to add a promising NASH drug to their product pipelines. But one name that continues to be left out in the cold is Intercept Pharmaceuticals (NASDAQ:ICPT).

  • [By George Budwell]

    If that line holds true, this emerging space should be able to support multiple new drugs, meaning that the current leaders in the field –Intercept Pharmceuticals (NASDAQ:ICPT) and Genfit — probably won’t be able to monopolize the market before other competitors like Viking get their drugs past the FDA. In fact, this market is so large it could feasibly support several blockbuster level products.

Top 10 Medical Stocks To Buy For 2019: Clearside BioMedical, Inc. (CLSD)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Here are some of the news articles that may have effected Accern Sentiment Analysis’s analysis:

    Get Catabasis Pharmaceuticals alerts:

    Analysts Offer Insights on Healthcare Companies: Clearside Biomedical (NASDAQ: CLSD) and Bluebird Bio (NASDAQ … (analystratings.com) Catabasis launches public equity offering (seekingalpha.com) Friedreich Ataxia Market Pipeline Therapeutics 2018 Top Key Players, Drug Profile and Product Description (thecleantechnology.com) Cellectis SA Receives a Buy from Oppenheimer (analystratings.com) Global Type I Hyperlipoproteinemia Drug Market 2018- Catabasis Pharmaceuticals, Inc., uniQure NV , Isis … (afinancialanalysis.com)

    Shares of Catabasis Pharmaceuticals traded down $0.28, reaching $1.06, on Monday, Marketbeat reports. The company’s stock had a trading volume of 2,344,684 shares, compared to its average volume of 645,019. The firm has a market cap of $38.91 million, a price-to-earnings ratio of -0.84 and a beta of 0.74. Catabasis Pharmaceuticals has a 52 week low of $1.00 and a 52 week high of $3.78.

  • [By Lisa Levin]

      

    Clearside Biomedical, Inc. (NASDAQ: CLSD) shares declined 32.19 percent to close at $9.86 on Thursday. Clearside Biomedical disclosed that its Phase 2 trial of CLS-TA met primary and secondary endpoints met in 6-month trial.
    scPharmaceuticals Inc. (NASDAQ: SCPH) shares dipped 30.1 percent to close at $9.94 on Thursday after the FDA identified deficiencies in the company’s New Drug Application for FUROSCIX. However, the FDA letter did not specify deficiencies identified and notification does not reflect final decision on information under review.
    Euroseas Ltd. (NASDAQ: ESEA) fell 24.08 percent to close at $1.86. Euroseas announced completion of the spin-off of its drybulk fleet into EuroDry Ltd.
    Golar LNG Limited (NASDAQ: GLNG) fell 25.09 percent to close at $25.98 following Q1 results.
    Oragenics, Inc. (NASDAQ: OGEN) shares dropped 25 percent to close at $1.50 on Thursday.
    Guess', Inc. (NYSE: GES) dropped 19.44 percent to close at $19.60 following Q1 results.
    Cantel Medical Corp. (NYSE: CMD) dropped 15.94 percent to close at $109.09 on Thursday following FQ3 results.
    Fusion Connect, Inc. (NASDAQ: FSNN) shares fell 15.55 percent to close at $3.91.
    Build-A-Bear Workshop, Inc. (NYSE: BBW) dropped 14.44 percent to close at $8.00 after reporting Q1 results.
    Dollar Tree, Inc. (NASDAQ: DLTR) shares declined 14.28 percent to close at $82.59 after the company reported weaker-than-expected earnings for its first quarter and lowered its FY2018 earnings guidance.
    Titan Machinery Inc. (NASDAQ: TITN) dropped 13.94 percent to close at $18.09 after reporting Q1 results.
    Co-Diagnostics, Inc. (NASDAQ: CODX) declined 13.17 percent to close at $2.90 after declining 5.65 percent on Wednesday.
    Concordia International Corp. (NASDAQ: CXRX) fell 12.89 percent to close at $0.2440 after the company announced that it would be delisted from the Nasdaq.
    Sears Holdings Corporation (NASDAQ: SHLD) slipped 12.46 percent

  • [By Keith Noonan]

    Clearside Biomedical, Inc. Stock (NASDAQ:CLSD)stock rose 66.1% in March, according to data provided byS&P Global Market Intelligence.

Top 10 Medical Stocks To Buy For 2019: Gorman-Rupp Company (GRC)

Advisors’ Opinion:

  • [By Logan Wallace]

    US Bancorp DE lessened its stake in shares of Gorman-Rupp (NYSE:GRC) by 3.6% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 136,614 shares of the industrial products company’s stock after selling 5,085 shares during the period. US Bancorp DE’s holdings in Gorman-Rupp were worth $3,996,000 at the end of the most recent reporting period.

Top 10 Medical Stocks To Buy For 2019: Blackrock Health Sciences Trust(BME)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Shares of B&M European Value Retail SA (LON:BME) have earned an average recommendation of “Buy” from the sixteen ratings firms that are covering the firm, MarketBeat Ratings reports. Five research analysts have rated the stock with a hold rating and eleven have issued a buy rating on the company. The average 12-month price target among brokers that have covered the stock in the last year is GBX 442.92 ($5.90).

  • [By Max Byerly]

    B&M European Value Retail (LON:BME) had its target price boosted by analysts at HSBC from GBX 470 ($6.26) to GBX 500 ($6.66) in a report released on Wednesday. The brokerage presently has a “buy” rating on the stock. HSBC’s price objective indicates a potential upside of 21.54% from the company’s current price.

Top 10 Medical Stocks To Buy For 2019: Liberty Property Trust(LPT)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Liberty Property Trust (LPT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Liberty Property Trust (LPT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    DekaBank Deutsche Girozentrale lowered its position in shares of Liberty Property Trust (NYSE:LPT) by 11.7% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 12,176 shares of the real estate investment trust’s stock after selling 1,608 shares during the period. DekaBank Deutsche Girozentrale’s holdings in Liberty Property Trust were worth $515,000 as of its most recent SEC filing.

Top 10 Medical Stocks To Buy For 2019: Eaton Vance New York Municipal Bond Fund(ENX)

Advisors’ Opinion:

  • [By Logan Wallace]

    Eaton Vance New York Municipal Bond Fund (NYSEAMERICAN:ENX) announced a monthly dividend on Thursday, July 5th, Wall Street Journal reports. Investors of record on Tuesday, July 24th will be paid a dividend of 0.0448 per share on Tuesday, July 31st. This represents a $0.54 dividend on an annualized basis and a dividend yield of 4.75%. The ex-dividend date of this dividend is Monday, July 23rd.

  • [By Logan Wallace]

    Eaton Vance New York Municipal Bond Fund (NYSEAMERICAN:ENX) announced a monthly dividend on Monday, June 4th, Wall Street Journal reports. Shareholders of record on Friday, June 22nd will be given a dividend of 0.0448 per share on Friday, June 29th. This represents a $0.54 annualized dividend and a yield of 4.77%. The ex-dividend date of this dividend is Thursday, June 21st.

  • [By Joseph Griffin]

    Euronext Amsterdam (EPA:ENX) has been assigned a €51.00 ($60.71) price target by investment analysts at UBS in a note issued to investors on Wednesday, www.boersen-zeitung.de reports. The firm presently has a “sell” rating on the stock. UBS’s target price would suggest a potential downside of 15.63% from the stock’s current price.

Top 10 Medical Stocks To Buy For 2019: Navios Maritime Partners LP(NMM)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Navios Maritime Partners (NMM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Buy For 2019: PetSmart Inc(PETM)

Advisors’ Opinion:

  • [By Shane Hupp]

    An issue of PetSmart, Inc. (NASDAQ:PETM) debt rose 1% against its face value during trading on Monday. The high-yield debt issue has a 8.875% coupon and is set to mature on June 1, 2025. The debt is now trading at $67.50 and was trading at $66.25 last week. Price moves in a company’s debt in credit markets often anticipate parallel moves in its share price.

  • [By Joseph Griffin]

    An issue of PetSmart, Inc. (NASDAQ:PETM) bonds fell 1.6% as a percentage of their face value during trading on Wednesday. The high-yield debt issue has a 8.875% coupon and is set to mature on June 1, 2025. The debt is now trading at $49.19 and was trading at $55.47 one week ago. Price changes in a company’s bonds in credit markets often predict parallel changes in its stock price.

Top 10 Medical Stocks To Buy For 2019: Akebia Therapeutics, Inc.(AKBA)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of Novo A’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Novo+A

    These are the top 5 holdings of Novo AInogen Inc (INGN) – 3,549,320 shares, 59.83% of the total portfolio. Acceleron Pharma Inc (XLRN) – 1,553,937 shares, 9.34% of the total portfolio. Dermira Inc (DERM) – 1,984,364 shares, 7.81% of the total portfolio. Shares added by 3.27%Corvus Pharmaceuticals Inc (CRVS) – 3,244,046 shares, 4.76% of the total portfolio. Akebia Therapeutics Inc (AKBA) – 2,225,000 shares, 4

  • [By Stephan Byrd]

    PNC Financial Services Group Inc. grew its holdings in shares of Akebia Therapeutics Inc. (NASDAQ:AKBA) by 653,850.0% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 313,896 shares of the biopharmaceutical company’s stock after buying an additional 313,848 shares during the quarter. PNC Financial Services Group Inc. owned 0.55% of Akebia Therapeutics worth $2,991,000 at the end of the most recent quarter.

  • [By Brian Feroldi]

    In response to the companies signing a merger agreement, shares ofAkebia Therapeutics (NASDAQ:AKBA) and Keryx Biopharmaceuticals (NASDAQ:KERX)fell 18% and 12%, respectively, as of 10:47 a.m. EDT on Thursday.

Top 10 Medical Stocks To Buy For 2019: International Bancshares Corporation(IBOC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    International Bancshares (NASDAQ: IBOC) and First Business Financial Services (NASDAQ:FBIZ) are both finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation and risk.

  • [By Ethan Ryder]

    BidaskClub upgraded shares of International Bancshares (NASDAQ:IBOC) from a hold rating to a buy rating in a research note published on Saturday.

    International Bancshares opened at $43.65 on Friday, MarketBeat reports. International Bancshares has a 1 year low of $32.50 and a 1 year high of $43.75. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.54. The stock has a market capitalization of $2.83 billion, a price-to-earnings ratio of 15.97 and a beta of 1.46.

  • [By Joseph Griffin]

    Shares of International Bancshares Co. (NASDAQ:IBOC) hit a new 52-week high and low during trading on Tuesday . The stock traded as low as $44.40 and last traded at $44.25, with a volume of 11252 shares. The stock had previously closed at $43.90.